Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 57 min ago
Peer-reviewedCC BY 4.0International Journal of Colorectal Disease

Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study

  1. 1Department of Colorectal and Anal Surgery, Inflammatory Bowel Disease Surgical Diagnosis and Treatment Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071 China
  2. 2Department of General Surgery, The Sixth Affiliated Hospital of Sun Yat-Sen University, Guangzhou, 510655 China

Abstract

Purpose: Patients with refractory perianal Crohn’s disease (RpCD) often face rectal resection and permanent ostomy as a final resort. The Turnbull–Cutait (TC) pull-through procedure offers a potential sphincter-preserving alternative, yet evidence supporting its use in RpCD remains scarce. This study evaluated the therapeutic efficacy of the TC procedure in this setting.

Methods: A retrospective analysis was conducted on ten patients with RpCD who planned to undergo TC surgery at Zhongnan Hospital of Wuhan University and the Sixth Affiliated Hospital of Sun Yat-sen University from January 2020 to June 2025; ultimately, eight patients completed the surgery. The median follow-up duration was 14.5 months.

Results: In the per-protocol analysis (n = 8), the incidence of postoperative complications during follow-up was 37.5%, including 1 case of anal fistula recurrence, 1 case of anal incontinence, and 1 case of rectovaginal fistula recurrence. Five patients achieved short-term technical success, yielding a short-term technical success rate of 62.5%. Their median gastrointestinal quality of life index (GIQLI) score was 138 points, indicating an overall high quality of life.

Conclusion: The TC procedure may serve as a salvage option to avoid permanent stoma in strictly selected patients with RpCD. Although short-term clinical improvement was observed in some patients, the relatively high complication rate and an uncertain long-term efficacy warrant cautious application and careful patient selection.

Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00384-026-05148-0.

Related

  1. Efficacy and specific toxicity profiles of GPRC5D- versus BCMA-targeted bispecific antibodies in relapsed/refractory multiple myeloma: a meta-analysis of clinical trials and real-world studies
    Jiahao Ji, Xinyu Zhao, Bin Wang +2
    Frontiers in immunologyPeer-reviewedCC BYFull textImmunologyEurope PMC
  2. Evaluating the efficacy of a novel endometrial receptivity test in improving pregnancy outcomes for Chinese in vitro fertilization patients: a single-center retrospective study
    Chunyan Ji, Xiaoyan Wang, Jinfang Yao +1
    BMC Pregnancy and ChildbirthPeer-reviewedCC BY 4.0Full textImmunologyPMC
  3. Efficacy evaluation of the cervical posterior “keyhole technique” in the treatment of cervical radiculopathy: A retrospective case series
    Ruohui Tang, Jin Yin, Zhixiang Zhang +3
    PLOS OnePeer-reviewedCC BY 4.0Full textNeuroscienceMedical imaging & radiologyPLOSPMC
  4. Efficacy of Starting Very-Low-Dose Cow's Milk Intake in Children Aged 1-12 Years With Severe Cow's Milk Allergy: A Retrospective Study.
    Kosei Yamashita, Takanori Imai, Sawa Seki +7
    Allergy, asthma & immunology researchPeer-reviewedCC BY-NCFull textImmunologyEurope PMC
  5. Efficacy and safety of sintilimab plus bevacizumab with or without transarterial chemoembolization for unresectable hepatocellular carcinoma: a propensity score-matched retrospective cohort study
    Zizhuo Wang, Bailu Wu, Chunshu Wu +7
    Frontiers in ImmunologyPeer-reviewedCC BY 4.0Full textImmunologyGeneral medicineCrossrefDOAJ
BibTeX
@article{tu2026efficacy,
  title = {{Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study}},
  author = {Qianwen Tu and Huanxin Hu and Mengting Zhang and Kangcheng Luo and Songlin Wan and Daojiang Li and Yi Li and Jia Ke and Zhao Ding},
  journal = {International Journal of Colorectal Disease},
  year = {2026},
  month = may,
  doi = {10.1007/s00384-026-05148-0},
  url = {https://doi.org/10.1007/s00384-026-05148-0},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Efficacy analysis of the Turnbull–Cutait procedure in refractory perianal Crohn’s disease: a two-centre retrospective study
AU  - Qianwen Tu
AU  - Huanxin Hu
AU  - Mengting Zhang
AU  - Kangcheng Luo
AU  - Songlin Wan
AU  - Daojiang Li
AU  - Yi Li
AU  - Jia Ke
AU  - Zhao Ding
PY  - 2026
DA  - 2026/05/14
JO  - International Journal of Colorectal Disease
DO  - 10.1007/s00384-026-05148-0
UR  - https://doi.org/10.1007/s00384-026-05148-0
AB  - Purpose: Patients with refractory perianal Crohn’s disease (RpCD) often face rectal resection and permanent ostomy as a final resort. The Turnbull–Cutait (TC) pull-through procedure offers a potential sphincter-preserving alternative, yet evidence supporting its use in RpCD remains scarce. This study evaluated the therapeutic efficacy of the TC procedure in this setting.  Methods: A retrospective analysis was conducted on ten patients with RpCD who planned to undergo TC surgery at Zhongnan Hospital of Wuhan University and the Sixth Affiliated Hospital of Sun Yat-sen University from January 2020 to June 2025; ultimately, eight patients completed the surgery. The median follow-up duration was 14.5 months.  Results: In the per-protocol analysis (n = 8), the incidence of postoperative complications during follow-up was 37.5%, including 1 case of anal fistula recurrence, 1 case of anal incontinence, and 1 case of rectovaginal fistula recurrence. Five patients achieved short-term technical success, yielding a short-term technical success rate of 62.5%. Their median gastrointestinal quality of life index (GIQLI) score was 138 points, indicating an overall high quality of life.  Conclusion: The TC procedure may serve as a salvage option to avoid permanent stoma in strictly selected patients with RpCD. Although short-term clinical improvement was observed in some patients, the relatively high complication rate and an uncertain long-term efficacy warrant cautious application and careful patient selection.  Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1007/s00384-026-05148-0.
SN  - 0179-1958
SN  - 1432-1262
ER  -